Breast Neoplasms
📧 Sign up to get email alerts when something new happens for Breast Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures [Phase 2]
Phase 2 trial update for afatinib in breast cancer patients who failed HER2-targeted treatment; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy [Phase 2]
Phase 2 trial evaluating epigallocatechin-3-gallate (EGCG) for skin prevention in breast cancer patients undergoing adjuvant radiotherapy.
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064) [Phase 2]
Phase II trial evaluating ridaforolimus with exemestane versus ridaforolimus, dalotuzumab, and exemestane in breast cancer was completed wit…
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors [Phase 1]
Phase 1 trial of talazoparib in advanced or recurrent solid tumors shows safety data and preliminary activity; results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant [Phase 2]
Phase 2 trial assessing oral azacitidine (CC-486) with fulvestrant in breast cancer was terminated; results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Influence of Exceptional Patient Characteristics on Everolimus Exposure [Phase 4]
Phase 4 clinical trial investigating how exceptional patient characteristics influence everolimus exposure in breast neoplasms.
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Nano MRI on 7 Tesla in Rectal and Breast Cancer [Phase 3]
Clinical trial update on Nano MRI using 7 Tesla for rectal and breast cancer conducted in Phase 3.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Evaluating Patient Information Prescriptions [Phase 2]
Phase 2 clinical trial update evaluating patient information prescriptions completed, sponsored by Johns Hopkins University.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) [Phase 3]
Phase 3 trial evaluating talazoparib in advanced/metastatic breast cancer with BRCA mutations has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Diagnostic Outcomes Of The Females Presenting With Breast Lump In Surgical Department Services Hospital Lahore
A completed clinical trial from Services Hospital Lahore evaluated the diagnostic outcomes for women presenting with a breast lump in the su…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Combined Intra-articular Shoulder Injection and Stellate Ganglion Block in Chronic Post-mastectomy Shoulder Pain [Phase 4]
Phase 4 clinical trial evaluating a combination of an intra-articular shoulder injection and a stellate ganglion block for chronic post-mast…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Ventilation Efficacy of Size 3 or Size 4 I-gel in Female Patient Weighing 50 to 60 Kilograms [NA]
Clinical trial update evaluating ventilation efficacy of I-gel sizes 3 or 4 in a female patient weighing 50 to 60 kilograms; current status …
-
CLINICAL_TRIALS research · 2018-05-02Clinical Trial Update: iNPWT in Immediate Breast Reconstruction [NA]
Clinical trial update on incisional negative pressure wound therapy (iNPWT) for immediate breast reconstruction; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer [Phase 2]
Phase 2 trial of letrozole and lapatinib followed by everolimus in women with advanced breast cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Study Evaluating HKI-272 in Tumors [Phase 1]
Phase 1 study evaluating HKI-272 (neratinib) in breast neoplasms has completed with results posted in 2018.
-
EMA withdrawal · 2018-02-02EMA Refused: Onzeald (etirinotecan pegol) — Nektar Therapeutics UK Limited
EMA refused approval of Onzeald (etirinotecan pegol) by Nektar Therapeutics UK Limited for breast neoplasms.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer [Phase 2]
A randomized phase II study evaluating pre-operative celecoxib treatment in breast cancer has completed.
-
EMA withdrawal · 2017-11-10EMA Application withdrawn: Kyomarc (bevacizumab) — Amgen Europe B.V.
The EMA withdrew the application for Kyomarc (bevacizumab) from Amgen Europe B.V., relating to several carcinomas and neoplasms.
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating neratinib (HKI-272) in subjects with advanced breast cancer has completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer [Phase 3]
Phase 3 trial comparing trastuzumab emtansine plus pertuzumab against chemotherapy plus trastuzumab and pertuzumab in HER2-positive breast c…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer [Phase 3]
Phase 3 trial evaluating safety and tolerability of assisted and self-administered subcutaneous trastuzumab as adjuvant therapy in early HER…
-
CLINICAL_TRIALS research · 2017-02-17Clinical Trial Update: Pectoral Nerves Blocks for Chronic Pain [EARLY_Phase 1]
Early phase 1 clinical trial update on using pectoral nerve blocks to treat chronic pain in patients with breast neoplasms; current status i…
-
EMA withdrawal · 2016-12-22EMA Withdrawn: Capecitabine SUN (capecitabine) — Sun Pharmaceutical Industries Europe B.V.
Capecitabine SUN (capecitabine) has been withdrawn from the European market by Sun Pharmaceutical Industries Europe B.V.
-
CLINICAL_TRIALS research · 2016-11-23Clinical Trial Update: Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions [Phase 2, Phase 3]
Clinical trial update on ultrasound-guided percutaneous microwave ablation for breast lesions (Phase 2/Phase 3); status is currently UNKNOWN…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid
A completed clinical trial evaluated the ForeCYTE Breast Aspirator for collecting nipple aspirate fluid and performing cytological testing i…